abstract |
The present invention relates to particular 6- (2-aminobenzylamino) purine of the general formula (I) used for the inhibition of CDKs, particularly in the treatment of viral infections and diseases that include cell proliferation such as tumors, psoriasis, restenosis, rheumatoid arthritis, etc. and pharmaceutical compositions comprising the same. |